Negative surgical margins regardless of surgery type was associated with increased overall survival in patients with Merkel cell carcinoma.

Analysts have set 12-month price targets for Teleflex, revealing an average target of $153.2, a high estimate of $191.00, and ...

As an investor, if you are uncomfortable with the risks and high valuation, there are two stocks well-positioned to be more ...

Some recommend scoring solid intraductal carcinoma as Gleason 5, but the cancer is linked to significantly poorer outcomes.

TransMedics' NOP advances organ transplantation with improved outcomes & cost reductions. See why I rate TMDX stock a strong ...

A total of 1 analyst ratings have been received for AngioDynamics, with the consensus rating being Buy. The average one-year price target stands at $15.0, suggesting a potential 59.74% upside.

As health systems face unrelenting pressure from workforce shortages, tightening financial margins, and growing patient ...

The incredibly high profit margins and perfect balance sheet as well as energy exposure that we didn't have in the MaM ...

Medicare and Medicaid can be saved — and made stronger — if decision makers focus on both the cost and the quality of ...

A new Parkland Institute report looks at how the cost of procedures at for-profit surgical clinics increased a whopping 79 ...

Intuitive Surgical is one of the most reliable growth stocks on the market. Palantir's revenue growth has now accelerated for six straight quarters, and its operating margin has improved for eight ...